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● Describe challenges, or threats, presented to different 
members along the drug supply chain.
● Identify strengths of organizations that have assisted 
with overcoming challenges during this time.
● Identify weaknesses of organizations that have made 
operations difficult during the COVID-19 pandemic.
● Recognize drug supply chain opportunities that have 
arisen from the COVID-19 pandemic.
● Evaluate the overall impact of COVID-19 on 
operations, outcomes, and patient care.
● The COVID-19 (Coronavirus) pandemic has altered 
the world and changed the means by which people 
approach various aspects of their lives.
● Businesses, governments, hospital systems, charities, 
and other organizations have had to adapt to adversity 
presented during the pandemic and modify operations.
● Notably, it is believed that COVID-19 directly and 
indirectly impacted the drug supply chain.
● There appeared to be a need to adapt traditional supply 
chain methods to complete operations and ultimately 
provide effective patient care.
●“At the very beginning, some things got slowed down, but 
then we quickly adapted and recovered.”
●“The COVID-19 pandemic pointed out weaknesses and 
vulnerabilities, but in the end it will strengthen our supply 
chain and we will be much stronger.”
●“This pandemic caused us to really pressure test 
evidence-based assumptions to make decisions for the 
sake of patients.”
●“In this market, when there’s chaos, there’s always huge 
opportunity to do well with a company.”
●“COVID-19 was a good test that proved the 
pharmaceutical drug supply system is resilient.”
●“Squeeze someone under pressure, and you will see what 
comes out. What you prioritize as a company will show 
up in times of crisis.”
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● Interview-style approach for information collection
● Personal one-on-one interviews, via video and phone 
calls, conducted with various members involved in 
steps throughout the drug supply chain:
○ Drug manufacturing
○ Wholesale/Distribution
○ Community Pharmacy (Independent and Chain)
○ Hospital Pharmacy
○ Mail Order Pharmacy
○ Nursing home / Specialty Packaging
○ Government (Ohio Board of Pharmacy)
● Written transcripts taken during each interview
● Many factors contribute to individual operations of each 
organization, but common themes can be identified.
● COVID-19 presented initial short-term challenges, but the 
supply chain has recovered over the long-term and has 
been strengthened by the pandemic.
● Despite initial fear and uncertainty, the pharmaceutical 
supply chain has demonstrated resilience.
● General theme expressed of ensuring employee safety 
while also meeting needs of customers/clients/patients
● Common strengths: proactive leadership, investment in 
technology, critical communication, teamwork, 
innovation, flexibility, proactiveness, trust amongst 
team members, strong community culture amongst team
● Common weaknesses: initial lack of preparedness, new 
forms of communication, inability to reach patients at 
home, sourcing too many materials from foreign 
countries, limited product availability for smaller 
organizations, lack of digital commerce front
● Common opportunities: work from home, decreased 
overhead costs, increased preparedness for future 
adversity, build loyalty with customers/clients/patients
● Common threats: staffing, receiving drug supplies, 
panic buying, proper allocation of resources, dispensing 
medications to patients, uncertainty of market, 
psychological drain of workers
● General theme that COVID-19 has not been as 
detrimental to long-term operations, outcomes, and 
patient care as originally anticipated
● Continue to watch for long-term impacts of COVID-19 on 
healthcare and the medication supply chain.
● Think about the potential impact COVID-19 has had 
pertaining to healthcare disparities and how this may affect 
economy, healthcare, and business operations long-term.
● Continue to educate others on organizational operations and 
challenges experienced by different organizations, as well as 
how organizations respond to presented challenges.
